Gentian Diagnostics ASA (OSL:GENT)
Norway · Delayed Price · Currency is NOK 39.80
0.00 (0.00%)
Nov 13, 2026, 4:25 PM CET
Gentian Diagnostics ASA Market Cap
Gentian Diagnostics ASA has a market cap or net worth of 615.25 million as of November 13, 2026. It is the 28,077th most valuable company in the world and the 193rd biggest in Norway. Its market cap has decreased by 29.76% in one year.
Market Cap
615.25M
Enterprise Value
539.79M
Revenue
191.35M
Global Rank
Country Rank
#193 Norway
PE Ratio
n/a
ChartMarket Cap Chart
Since December 14, 2016, Gentian Diagnostics ASA's market cap has increased from 289.62M to 615.25M, an increase of 112.44%. That is a compound annual growth rate of 7.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 615.25M | -29.27% |
| Dec 30, 2025 | 869.82M | 43.88% |
| Dec 30, 2024 | 604.56M | -5.54% |
| Dec 29, 2023 | 640.03M | 1.22% |
| Dec 30, 2022 | 632.32M | -43.06% |
| Dec 30, 2021 | 1.11B | 32.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 5.73B |
| Circio Holding ASA | 2.73B |
| Nordhealth AS | 2.07B |
| Thor Medical ASA | 1.72B |
| ArcticZymes Technologies ASA | 1.10B |
| Omda AS | 943.35M |
| Vistin Pharma ASA | 858.07M |
| Lytix Biopharma ASA | 736.70M |